Clinical trial
Use of Etonogestrel-releasing Contraceptive Implant in Women With Sickle Cell Disease
NCT02594462 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of Etonogestrel-releasing Contraceptive Implant in Women With Sickle Cell Disease
- Lead sponsor
- University of Sao Paulo
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2015
- Completion date
- June 30, 2019
- Enrollment
- 29 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
sickle cell disease